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Abstract
Background: The rates of cesarean section (CS) are increasing worldwide leading to an increased risk for maternal
and neonatal complications in the subsequent pregnancy and labor. Previous studies have demonstrated that successful
trial of labor after cesarean (TOLAC) is associated with the least maternal morbidity, but the risks of unsuccessful TOLAC
exceed the risks of scheduled repeat CS. However, prediction of successful TOLAC is difficult, and only limited data on
TOLAC in women with previous failed labor induction or labor dystocia exists. Our aim was to evaluate the success of
TOLAC in women with a history of failed labor induction or labor dystocia, to compare the delivery outcomes according
to stage of labor at time of previous CS, and to assess the risk factors for recurrent failed labor induction or labor dystocia.
Methods: This retrospective cohort study of 660 women with a prior CS for failed labor induction or labor dystocia
undergoing TOLAC was carried out in Helsinki University Hospital, Finland, between 2013 and 2015. Data on the study
population was obtained from the hospital database and analyzed using SPSS.
Results: The rate of vaginal delivery was 72.9% and the rate of repeat CS for failed induction or labor dystocia was 17.7%.
The rate of successful TOLAC was 75.6% in women with a history of labor arrest in the first stage of labor, 73.1% in
women with a history of labor arrest in the second stage of labor, and 59.0% in women with previous failed induction.
The adjusted risk factors for recurrent failed induction or labor dystocia were maternal height < 160 cm (OR 1.9 95% CI
1.1–3.1), no prior vaginal delivery (OR 8.3 95% CI 3.5–19.8), type 1 or gestational diabetes (OR 1.8 95% CI 1.0–3.0), IOL for
suspected non-diabetic fetal macrosomia (OR 10.8 95% CI 2.1–55.9) and birthweight ≥4500 g (OR 3.3 95% CI 1.3–7.9).
Conclusions: TOLAC is a feasible option to scheduled repeat CS in women with a history of failed induction or labor
dystocia. However, women with no previous vaginal delivery, maternal height < 160 cm, diabetes or suspected
neonatal macrosomia (≥4500 g) may be at increased risk for failed TOLAC.
Keywords: Cesarean section, Induction of labor, Labor dystocia, Trial of labor after cesarean (TOLAC)
Background
The rates of cesarean section (CS) are increasing world-
wide. In Finland, the rate of CS is 16% of all births, and
20% in primiparous women, being the lowest figures
among the western countries [1]. Since CS leads to an
increased risk for abnormally attached placenta, uterine
rupture, and maternal and neonatal complications in the
subsequent pregnancy and labor [2], an abundance of
research has been conducted to assess the feasibility and
safety of trial of labor after cesarean (TOLAC) [3, 4].
Previous studies suggest that the mode of delivery with
the least maternal morbidity for a woman with a history
of prior low transverse CS is successful TOLAC [5–7],
but the risks of unsuccessful TOLAC are higher than
the risks of scheduled repeat CS [6]. However, prediction
of successful TOLAC is difficult. TOLAC is suggested to
be cost-effective compared to a repeat planned CS [8],
and when considering long-term consequences, TOLAC
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with a success rate of 47% or more appears more eco-
nomical than a repeat planned CS [9].
As shown by previous studies, the indication of the
previous CS influences the success rate of TOLAC.
Women with a previous CS for labor dystocia (non-pro-
gressing labor) have a lower rate of successful TOLAC
compared to women with a nonrecurring CS indication
such as breech presentation or fetal distress [10, 11].
The greatest predictor for successful TOLAC is a prior
vaginal delivery [4, 12]. Prelabor nomograms have been
presented to predict successful TOLAC [13, 14], but the
data on induction of labor (IOL) in women with a his-
tory of previous CS for failed induction or labor dystocia
is limited [15].
Our primary aim was to evaluate the success of
TOLAC, including IOL, in this subgroup of women, and
to compare delivery outcomes according to stage of
labor at time of the previous CS. We also wanted to
assess risk factors for repeat CS for recurrent failed labor
induction or labor dystocia.
Methods
This retrospective cohort study of women with a history
of previous emergency CS for labor dystocia or failed
labor induction was carried out in the Department of
Obstetrics and Gynecology of Helsinki University
Hospital, Finland. All women with a vital singleton term
pregnancy, cephalic presentation, and previous lower
segment transverse CS for failed labor induction or labor
dystocia undergoing TOLAC between January 1st 2013
and January 1st 2015 were identified in the hospital
database. Women with scheduled repeat CS, preterm
delivery, breech presentation, twin pregnancy or fetal
demise were excluded (Fig. 1). Women undergoing IOL
and women with spontaneous onset of labor were both
included in the study (Fig. 1). The study protocol was
approved by the management of Hospital district of
Helsinki and Uusimaa. An informed consent was not
required since this was a retrospective cohort study
approved by the hospital management.
Data on the study population characteristics and labor
and delivery outcomes were obtained from individual
patient charts in the hospital database.
Gestational age was determined by the crown-rump-
length measurement at the time of the first trimester
ultrasound screening. Obesity was defined as BMI ≥35 kg/m2,
and gestational diabetes was diagnosed by a 2-h 75 g
oral glucose tolerance test. Medication-dependent ges-
tational diabetes included both insulin and metformin
treatments. Post-term pregnancy was defined as gesta-
tional age ≥ 42+ 0 weeks. Fetal macrosomia was defined
by birthweight ≥4500 g. In case of term premature
rupture of membranes (PROM), labor was induced
after 24 h of expectant management.
The indications for labor induction were categorized
as post-term pregnancy, PROM, gestational diabetes,
suspected non-diabetic fetal macrosomia, fetal reason and
maternal reason. Fetal reason for labor induction included
oligohydramnios, polyhydramnios, nonreassuring cardioto-
cograph, intrauterine growth restriction, Rh-immunization,
reduced fetal movements, prevention of fetal malposition
after successful external cephalic version, and gastrointes-
tinal anomalies. Maternal reason for labor induction in-
cluded pre-eclampsia, intrahepatic cholestasis of pregnancy,
maternal medical condition, exhaustion, psychosocial rea-
sons, and complications in an earlier pregnancy such as
previous intrauterine death or shoulder dystocia.
Labor induction was carried out by artificial rupture of
membranes (amniotomy) and oxytocin in case of a
favorable cervix (Bishop score ≥ 6). In case of an un-
favorable cervix, a single 50 ml Foley catheter (FC, Rüsh
2-way Foley, Couvelaire tip, catheter size 22Ch, Teleflex
Medical, Athlone, Ireland) or misoprostol (Cytotec, Piramal
Healthcare UK Limited, Northumberland, England) were
used for cervical ripening. FC was retained for a maximum
of 24 h. Misoprostol was administered 50 μg orally or 25 μg
vaginally every 4 h until Bishop score ≥ 6 was achieved.
Amniotomy was performed when the cervix was favorable,
and oxytocin was started after 2–12 h if contractions
deemed inadequate. Continuous fetal cardiotocography
was routinely used during labor.
Failed labor induction was defined as failure to pro-
gress in the setting of ruptured membranes, oxytocin
infusion for ≥12 h, and cervical dilation < 6 cm [16].
Labor dystocia in the first stage of labor was defined as
failure to progress at cervical dilation ≥6 cm with rup-
tured membranes and adequate contractions for a mini-
mum of 4 h [16]. Labor dystocia in the second stage of
labor was defined as failure to deliver at cervical dilation
of 10 cm despite of ≥1 h of active pushing or failed op-
erative vaginal delivery [16].
The primary outcomes were the rate of repeat CS and
the rate of recurring failed labor induction or labor
dystocia. The secondary outcomes were the rates of
uterine rupture, postpartum hemorrhage ≥1000 ml, ma-
ternal intrapartum and postpartum infections, and ad-
verse neonatal primary outcome [17, 18].
Adverse neonatal primary outcome was defined as a
5-min Apgar-score < 7, umbilical artery blood pH-value
< 7.05, or base excess (BE) value <− 12 [17, 18]. Uterine
rupture was defined as a complete rupture of both myo-
metrium and visceral peritoneum. Intrapartum infection
was defined as fever ≥38 °C, fetal tachycardia, and total
white cell count ≥20 e9/l. Postpartum infection included
endometritis (defined as fever ≥38 °C, total white cell
count ≥20 e9/l, uterine tenderness, and purulent vaginal
discharge), clinical wound infection, and urinary tract in-
fection verified by a positive finding in urine culture.
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Statistical analysis was performed by using IBM SPSS
Statistics for Windows, Version 25.0 (Armonk, NY,
USA). Data with categorical variables were compared by
Pearson’s Chi-square test. Unpaired comparisons of con-
tinuous variables were carried out by Student’s t-test
when the data were normally distributed. Multivariate
logistic regression analyses were performed to assess
relative risks for unsuccessful TOLAC and recurrent CS
for failed labor induction or labor dystocia. Adjusted
odd ratios (OR) with 95% confidence intervals (CI) were
calculated by modelling the data to control for possible
confounding factors. All variables used in the multivariate
analyses are shown in the tables with respective univariate
analyses. A p-value < 0.05 was considered statistically
significant.
Results
A total of 660 women with a prior CS for failed labor in-
duction or labor dystocia were included. Of the women,
226 (34.2%) underwent IOL and 434 (65.8%) women had
spontaneous onset of labor. A total of 481 women
(72.9%) had successful TOLAC. Table 1 presents the
characteristics of the study population. The women with
unsuccessful TOLAC were shorter, more obese, more
often had post-term pregnancy, diabetes, no prior vagi-
nal delivery, and more often underwent IOL (Table 1). A
total of 519 women (78.6%) had no prior vaginal deliv-
ery, 26 women (3.9%) had delivered vaginally prior to
the CS, 106 women (16.1%) had delivered vaginally after
the CS, and nine women (1.4%) had prior vaginal delivery
both prior to and after the CS. The most common indica-
tion for IOL in the current pregnancy was post-term preg-
nancy (n = 65, 28.8%) (Table 1). FC was used as the
primary method for IOL in 135 (59.7%) women, misopros-
tol in 20 (8.8%) women, and amniotomy and oxytocin in
71 (31.4%) women.
The delivery outcomes are presented in Tables 2 and 3.
Four cases (0.6%) of uterine rupture occurred (Tables 2
and 3), all in women with no prior vaginal delivery. Three
of the uterine ruptures occurred following spontaneous
onset of labor and one case occurred following amniot-
omy and oxytocin induction. There were no cases of
hysterectomy. The overall rate of maternal intrapar-
tum infection was 2.9% and postpartum infection
2.4% (Tables 2 and 3). Intrapartum infections and
postpartum hemorrhage more often occurred following
unsuccessful TOLAC compared to successful TOLAC
(Table 2). The rates of oxytocin use (92.9% vs. 89.9%, p =
0.21) and epidural or spinal analgesia (86.3% vs. 89.4%,
p = 0.29) were similar. No significant difference in the
rates of adverse primary neonatal outcomes was seen
between the groups (Tables 2 and 3). Seventeen (2.6%)
neonates had an umbilical artery blood pH < 7.05 at
birth, and 26 (3.9%) had a 5-min Apgar score < 7.
The rate of successful TOLAC was 75.6% in women
with a history of labor arrest in the first stage of labor,
73.1% in women with a history of labor arrest in the sec-
ond stage of labor, and 59.0% in women with a history of
Fig. 1 Flow chart of the study population
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failed labor induction (Table 3). The overall rate of re-
curring failed labor induction or labor dystocia leading
to repeat CS was 17.7%, being 15.9% in women with a
history of labor arrest in the first stage of labor, 17.3% in
women with a history of labor arrest in the second stage
of labor, and 27.0% in women with a history of failed
labor induction (p = 0.01) (Table 3). Infections were
more common in the subgroup of women with previous
failed labor induction (Table 3). Seventy-seven women
with a history of failed labor induction underwent IOL
also in the current pregnancy (Table 3). Of these, 40
women (51.9%) had a successful TOLAC, 26 women
(33.8%) had repeat CS for labor dystocia, and 18 (23.4%)
women had recurrent failed IOL.
The risk factors for unsuccessful TOLAC are presented
in Table 4, and the risk factors for recurring failed labor
induction or labor dystocia are presented in Table 5. After
adjustment, maternal height < 160 cm (OR 1.9), no prior
vaginal delivery (OR 8.3), type 1 or gestational diabetes (OR
1.8), IOL for suspected non-diabetic fetal macrosomia (OR
Table 1 Characteristics of the study population in trial of labor after cesarean (TOLAC) n = 660
Successful TOLAC Unsuccessful TOLAC
n = 481 % n = 179 % p
Maternal age≥ 37 77 16.0 38 21.2 0.12
IVF 13 2.7 3 1.7 0.45
Smoking 33 6.9 15 8.4 0.5
Height < 160 cm 97 20.2 50 27.9 0.03
BMI≥ 35 34 7.1 19 10.6 0.01
Diabetes 1211 25.2 632 35.2 0.01
Prior vaginal delivery 124 25.8 17 9.5 < 0.001
More than 2 years from previous CS 289 60.1 117 65.4 0.22
Medication-dependent gestational diabetes 25 5.5 14 8.5 0.64
Post-term pregnancy (≥42 weeks) 35 7.3 29 16.2 0.001
Labor induction 143 29.7 83 46.4 < 0.001
Bishop < 6 at the start of induction 95 66.4 58 69.8 0.59
Indication for labor induction
Post-term 37 25.9 28 33.7 0.21
PROM 27 18.9 17 20.5 0.77
Diabetes 283 19.6 124 14.5 0.33
Non-diabetic macrosomia 3 2.1 4 4.8 0.26
Fetal reason 8 5.6 8 9.6 0.25
Maternal reason 40 28.0 14 16.9 0.06
1of which 4 women with diabetes type 1 and 117 with gestational diabetes
2of which 1 woman with diabetes type 1 and 62 with gestational diabetes
3of which 3 women with diabetes type 1 and 25 with gestational diabetes
4of which all women with gestational diabetes
Table 2 Maternal and neonatal outcomes in successful and unsuccessful trial of labor after cesarean (TOLAC) (n = 660)
Successful TOLAC Unsuccessful TOLAC
n = 481 % n = 179 % p-value
Uterine rupture 0 0.0 4 2.2
Intrapartum infection 4 0.8 15 8.4 < 0.001
Postpartum infection 10 2.1 6 3.4 0.344
Blood culture positive septicemia 1 0.2 0 0
Postpartum hemorrhage ≥1000ml 72 15.0 54 30.2 < 0.001
Birthweight ≥4500 g 16 3.3 13 7.3 0.028
Adverse neonatal primary outcome 331 6.9 162 8.9 0.37
1missing values in data: pH n = 1, BE n = 57
2missing values in data: pH n = 2, BE n = 33
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Table 3 Delivery outcomes in the subgroups of women with a history of labor dystocia in the first stage of labor, labor dystocia in
the second stage of labor and failed labor induction (n = 660)
Labor arrest in the 1st stage Labor arrest in the 2nd stage Failed labor induction
n = 508 % n = 52 % n = 100 % p
IOL in current pregnancy 127 25.0 22 42.3 77 77 < 0.001
Mode of delivery
Spontaneous vaginal delivery 318 62.6 30 57.7 42 42 0.001
Operative vaginal delivery 66 13.0 8 15.4 17 17 0.54
Cesarean section 124 24.4 14 26.9 41 41 0.003
Cesarean section indication
Labor arrest in the 1st stage 49 9.6 5 9.6 8 8 0.07
Labor arrest in the 2nd stage 24 4.7 4 7.7 1 1 0.007
Failed labor induction 8 1.6 0 0 18 18 < 0.001
Fetal distress 37 7.3 2 3.8 9 9 0.33
Other 61 1.2 32 5.8 53 5 0.04
Postpartum hemorrhage ≥1000ml 89 17.5 15 28.8 22 22 0.1
Intrapartum infection 11 2.2 2 3.8 6 6 0.07
Postpartum infection 10 2.0 0 0 6 6 0.04
Blood culture positive septicemia 1 0.2 0 0 0 0 1
Uterine rupture 3 0.6 0 0 1 1.0 0.65
Birthweight ≥4500 g 21 4.1 2 3.8 6 6 0.62
Adverse neonatal primary outcome 39 7.7 1 1.9 9 9 0.27
1 suspicion of uterine rupture/dehiscence n = 1, intrapartum infection n = 2, maternal request for fear of labor n = 2, fetal malpresentation n = 1
2 intrapartum infection n = 2, maternal request for fear of labor n = 1
3 intrapartum infection n = 3, maternal request for fear of labor n = 1, preeclampsia n = 1
Table 4 Risk factors for unsuccessful trial of labor after cesarean (TOLAC) (n = 179)
Unadjusted unsuccessful TOLAC Adjusted unsuccessful TOLAC
OR CI (95%) p-value OR CI (95%) p-value
Maternal age≥ 37 1.4 0.9–2.2 0.12 1.6 1.0–2.7 0.05
IVF 1.6 0.5–5.8 0.45 0.5 0.1–2.1 0.36
Smoking 1.2 0.7–2.3 0.51 1.4 0.7–2.9 0.35
Height < 160 cm 1.5 1.0–2.3 0.03 1.7 1.1–2.7 0.01
BMI≥ 35 1.6 0.9–2.8 0.14 1.5 0.8–2.9 0.21
No prior vaginal delivery 3.3 1.9–5.7 < 0.001 4.9 2.7–9.0 < 0.001
More than 2 years from previous CS 1.3 0.9–1.8 0.22 1.6 1.1–2.4 0.02
Diabetes, type 1 or gestational 1.6 1.1–2.3 0.01 1.7 1.0–2.6 0.03
Medication-dependent gestational diabetes 1.5 0.8–3.0 0.21 2.1 0.9–5.2 0.11
Post-term pregnancy (≥42 weeks) 2.5 1.5–4.2 0.001 1.5 0.6–4.0 0.43
Labor induction for post-term pregnancy 2.2 1.3–3.8 0.003 1.5 0.6–4.0 0.43
Labor induction for premature rupture of membranes 1.8 0.9–3.3 0.08 2.1 1.0–4.1 0.04
Labor induction for diabetes 1.2 0.6–2.3 0.67 0.7 0.3–1.8 0.47
Labor induction for non-diabetic macrosomia 3.6 0.8–16.4 0.09 5.9 1.2–29.2 0.03
Labor induction for fetal reason 2.8 1.0–7.5 0.05 4.2 1.5–12.2 0.007
Labor induction for maternal reason 0.94 0.5–1.8 0.84 1.3 0.7–2.6 0.46
Birthweight ≥4500 g 2.3 1.1–4.8 0.03 2.4 1.1–5.5 0.03
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10.8) and birthweight ≥4500 g (OR 3.3) remained significant
risk factors for recurrent failed induction or labor dystocia
and repeat CS (Table 5). In the subgroup of women
with a history of previous failed labor induction, the ad-
justed risk factors for recurrent failed labor induction
or labor dystocia were smoking (OR 10.5), BMI ≥35
(OR 5.3), and induction of labor for reasons other than
PROM or diabetes (Table 6).
Discussion
Our results show a relatively high success rate of 73%
for TOLAC in women with a history of previous failed
labor induction or labor dystocia. Lower vaginal delivery
rates of 49–68% following TOLAC for non-progressive
labor have previously been reported [11, 12, 15, 19–23].
Our results suggest that the highest rate of repeat CS oc-
curs in women with a history of failed labor induction
compared to women with labor dystocia in the first or
second stage of labor. Furthermore, every fifth woman
with a history of failed labor induction had recurring
failed IOL.
The greatest predictor for successful TOLAC is a prior
vaginal delivery [4], as also seen in our study. However,
two thirds of the women with no prior vaginal delivery
in our study also had successful TOLAC. Women
undergoing IOL had lower success rate of TOLAC com-
pared to women with spontaneous onset of labor, as re-
ported previously [11, 24]. Increasing maternal age and
BMI may propose a greater risk for CS [4, 25–28]. In
this study, maternal age ≥ 37 years was associated with
repeat CS, and BMI ≥ 35 was associated with recurring
failed labor induction or labor dystocia in the subgroup
of women with a history of induction failure. In our
study, maternal height < 160 cm was associated with an
increased risk for repeat CS. This is in line with previous
studies suggesting that shorter maternal stature appears
an independent risk factor for induction failure, and
taller women are more likely to have a vaginal delivery
[29, 30]. Also, increasing neonatal birth weight > 4000 g
has been shown to increase the risk for a recurrent CS
[31–33], which is in agreement with our results.
The overall rate of uterine rupture was low (0.6%) in
our study. Higher rates of uterine rupture have been
reported following IOL compared to spontaneous onset
of labor [24, 34–36], while contradictive results have also
been presented [37]. In our study, three of the four uter-
ine ruptures occurred following spontaneous onset of
labor. The women with uterine rupture had no prior va-
ginal delivery, which may increase the risk for uterine
rupture [34]. The method of choice for IOL in women
with an unfavorable cervix and a history of previous CS
is FC [38, 39]. Some women in our study received miso-
prostol for IOL despite of the uterine scar, even though
this is not supported by our clinical guidelines. However,
no uterine ruptures occurred in these women.
The rate of postpartum hemorrhage in our study was
higher than previously reported [40, 41]. Increased
post-partum hemorrhage more often occurred following
Table 5 Risk factors for recurrent cesarean section for failed labor induction or labor dystocia (n = 117)
Unadjusted recurrent failed induction or labor
dystocia
Adjusted recurrent failed induction or labor
dystocia
OR CI (95%) p-value OR CI (95%) p-value
Maternal age≥ 37 1.2 0.7–2.1 0.47 1.4 0.8–2.6 0.23
IVF 1.0 0.3–3.4 0.93 0.88 0.2–3.6 0.85
Smoking 1.3 0.6–2.7 0.53 1.8 0.8–4.1 0.18
Height < 160 cm 1.6 1.0–2.6 0.04 1.9 1.1–3.1 0.01
BMI≥ 35 1.6 0.8–3.2 0.15 1.6 0.8–3.4 0.22
No prior vaginal delivery 5.5 2.5–12.0 < 0.001 8.3 3.5–19.8 < 0.001
More than 2 years from previous CS 1.0 0.7–1.5 0.96 1.3 0.8–2.0 0.31
Diabetes, type 1 or gestational 1.7 1.1–2.6 0.02 1.8 1.0–3.0 0.04
Medication-dependent gestational diabetes 1.5 0.7–3.4 0.3 1.8 0.6–5.3 0.27
Post-term pregnancy (≥42 weeks) 2.3 1.3–4.3 0.007 2.3 0.7–7.3 0.15
Labor induction for post-term pregnancy 1.9 1.0–3.6 0.044 1.1 0.3–3.7 0.84
Labor induction for premature rupture of membranes 1.7 0.8–3.6 0.14 2.1 0.9–4.7 0.07
Labor induction for diabetes 1.5 0.7–3.2 0.28 1.0 0.4–2.8 0.98
Labor induction for non-diabetic macrosomia 5.6 1.3–25.6 0.03 10.8 2.1–55.9 0.005
Labor induction for fetal reason 2.1 0.6–7.1 0.24 3.2 0.9–11.7 0.75
Labor induction for maternal reason 0.9 0.4–2.0 0.83 1.4 0.4–3.2 0.4
Birthweight ≥4500 g 3.0 1.4–6.7 0.007 3.3 1.3–7.9 0.009
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unsuccessful TOLAC, as also previously reported [24].
The rates of maternal infections were also consistent
with previous studies [5, 34, 40]. Higher rate of maternal
morbidity and endometritis have been shown to occur in
women with an unsuccessful TOLAC compared to
women with a successful TOLAC [5], and a similar
trend was seen also in our study. Adverse neonatal pri-
mary outcomes were not frequent following TOLAC,
which is in line with previous studies [23, 40].
The strengths of our study were the relatively large
sample size, the systematic and detailed medical records,
and standardized labor management protocol in our
hospital. The major weaknesses of this study are the
retrospective design and not including the women deliv-
ering by a planned CS, which may have caused a poten-
tial bias. Also, this study may have lacked power to
detect possible associations between several important
variables. We regret not having the data on estimated
fetal weight available in our study, but as a surrogate, we
used birthweight. A previous study indicated that a 500
g increase in birthweight in current pregnancy, com-
pared to the pregnancy with labor dystocia, decreases
the rate of a successful TOLAC [27]. Furthermore, un-
fortunately we did not have the data on cervical dilation
at the previous CS, as cervical dilation of 7 cm or more
has been suggested to increase the likelihood of success-
ful TOL in the subsequent pregnancy [12, 21, 22].
Conclusions
TOLAC, including both spontaneous and induced labor,
is a feasible option for scheduled repeat CS in women
with a history of previous failed labor induction or labor
dystocia. However, our results suggest that women with
no previous vaginal delivery, maternal height < 160 cm,
diabetes, and suspected neonatal macrosomia (≥4500 g)
may be at increased risk for failed trial of labor. Also,
BMI ≥35, smoking, no prior vaginal delivery and induc-
tion of labor for reasons other than PROM may be asso-
ciated with recurring failed induction or labor dystocia.
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